Patents by Inventor Yasuyoshi Iso

Yasuyoshi Iso has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9156830
    Abstract: The invention relates to compounds of Formula I: wherein Ar1, Ar2, Ar3, L1, L2, Y, Z and v are defined in the specification, and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative thereof.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: October 13, 2015
    Assignee: SHIONOGI & CO., LTD.
    Inventors: Noriyuki Kurose, Yasuyoshi Iso, Naoko Yamaguchi, Bin Shao, Laykea Tafesse, Xiaoming Zhou, Jianming Yu
  • Publication number: 20140249159
    Abstract: The invention relates to compounds of Formula I: wherein Ar1, Ar2, Ar3, L1, L2, Y, Z and v are defined in the specification, and pharmaceutically acceptable derivatives thereof, compositions comprising an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative thereof, and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a compound of Formula I or a pharmaceutically acceptable derivative thereof.
    Type: Application
    Filed: May 16, 2012
    Publication date: September 4, 2014
    Inventors: Noriyuki Kurose, Kayoko Hata, Yasuyoshi Iso, Naoko Yamaguchi, Bin Shao, Laykea Tafesse, Xiaoming Zhou, Jianming Yu
  • Patent number: 8088924
    Abstract: It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R1 is a group represented by the formula: —Y1—Y2—Y3—Ra wherein Y1 is single bond or the like; Y2 is —C(?O)—NH— or the like; Y3 is optionally substituted aryl or the like; R2 is hydrogen or the like; R3 is alkyl or the like; R4 is alkyl or the like; R5 is optionally substituted alkyl or the like; or R3 and R4 taken together with the adjacent atom form cyclic group or the like.
    Type: Grant
    Filed: September 2, 2009
    Date of Patent: January 3, 2012
    Assignee: Shionogi & Co., Ltd.
    Inventors: Yukio Tada, Yasuyoshi Iso, Kohji Hanasaki
  • Publication number: 20100081686
    Abstract: It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R1 is a group represented by the formula: —Y1—Y2—Y3—Ra wherein Y1 is single bond or the like; Y2 is —C(?O)—NH— or the like; Y3 is optionally substituted aryl or the like; R2 is hydrogen or the like; R3 is alkyl or the like; R4 is alkyl or the like; R5 is optionally substituted alkyl or the like; or R3 and R4 taken together with the adjacent atom form cyclic group or the like.
    Type: Application
    Filed: September 2, 2009
    Publication date: April 1, 2010
    Inventors: Yukio TADA, Yasuyoshi ISO, Kohji HANASAKI
  • Patent number: 7652141
    Abstract: It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R1 is a group represented by the formula: —Y1—Y2—Y3—Ra wherein Y1 is single bond or the like; Y2 is —C(?O)—NH— or the like; Y3 is optionally substituted aryl or the like; R2 is hydrogen or the like; R3 is alkyl or the like; R4 is alkyl or the like; R5 is optionally substituted alkyl or the like; or R3 and R4 taken together with the adjacent atom form cyclic group or the like.
    Type: Grant
    Filed: June 29, 2005
    Date of Patent: January 26, 2010
    Assignee: Shionogi & Co., Ltd.
    Inventors: Yukio Tada, Yasuyoshi Iso, Kohji Hanasaki
  • Publication number: 20060052411
    Abstract: It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R1 is a group represented by the formula: —Y1—Y2—Y3—Ra wherein Y1 is single bond or the like; Y2 is —C(?O)—NH— or the like; Y3 is optionally substituted aryl or the like; R2 is hydrogen or the like; R3 is alkyl or the like; R4 is alkyl or the like; R5 is optionally substituted alkyl or the like; or R3 and R4 taken together with the adjacent atom form cyclic group or the like.
    Type: Application
    Filed: June 29, 2005
    Publication date: March 9, 2006
    Inventors: Yukio Tada, Yasuyoshi Iso, Kohji Hanasaki
  • Patent number: 6977266
    Abstract: It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): ? wherein R1 is a group represented by the formula: —Y1—Y2—Y3—Ra wherein Y1 is single bond or the like; Y2 is —C(?O)—NH— or the like; Y3 is optionally substituted aryl or the like; R2 is hydrogen or the like; R3 is alkyl or the like; R4 is alkyl or the like; R5 is optionally substituted alkyl or the like; or R3 and R4 taken together with the adjacent atom form cyclic group or the like.
    Type: Grant
    Filed: December 26, 2001
    Date of Patent: December 20, 2005
    Assignee: Shionogi & Co., Ltd.
    Inventors: Yukio Tada, Yasuyoshi Iso, Kohji Hanasaki
  • Publication number: 20040082619
    Abstract: It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): 1
    Type: Application
    Filed: June 30, 2003
    Publication date: April 29, 2004
    Inventors: Yukio Tada, Yasuyoshi Iso, Kohji Hanasaki